LIVIVO - Search results -

Search results

Result 1 - 10 of total 357

Search options

Article ; Online: Early Childcare Precarity and Subsequent Maternal Health.

Duh-Leong, Carol / Canfield, Caitlin F / Fuller, Anne E / Gross, Rachel S / Reichman, Nancy E

Women's health issues : official publication of the Jacobs Institute of Women's Health

2023 Volume 34, Issue 2, Page(s) 115–124

Abstract: Purpose: We examined prospective associations between early childcare precarity, or the security and reliability of childcare arrangements, and subsequent maternal health.: Study design: We conducted a secondary analysis of survey responses from ... ...

Abstract	Purpose: We examined prospective associations between early childcare precarity, or the security and reliability of childcare arrangements, and subsequent maternal health. Study design: We conducted a secondary analysis of survey responses from mothers of 2,836 children in the Future of Families and Child Wellbeing study. We assessed the following childcare measures: insecure childcare, insecure childcare with missed work, inadequate childcare, and emergency childcare support. We used linear and logistic regression models with robust standard errors to examine associations between these measures when the index child was age 3 and maternal health outcomes (overall health, depression, and parenting stress) later when the child was age 9. We then examined additive experiences of childcare measures across child ages 1 and 3 on maternal health outcomes. Results: Early inadequate childcare was associated with higher odds of later poor maternal overall health (adjusted odds ratio [aOR], 1.64; 95% confidence interval [CI], 1.11-2.41). All early childcare precarity measures were associated with higher odds of maternal depression (insecure childcare [aOR, 1.64; 95% CI, 1.23-2.18]; insecure childcare with missed work [aOR, 1.58; 95% CI, 1.13-2.22]; and inadequate childcare [aOR, 1.75; 95% CI, 1.22-2.51]). Emergency childcare support was associated with lower odds of adverse maternal health outcomes (poor overall health [aOR, 0.65; 95% CI, 0.48 to 0.88]; depression [aOR, 0.73; 95% CI, 0.54 to 0.99]; and parenting stress [B -0.45; 95% CI, -0.80 to -0.10]). Prolonged experiences had stronger associations with maternal health than shorter experiences. Conclusion: Early childcare precarity has long-term adverse associations with maternal health, and emergency childcare support seems to be favorable for maternal health. These findings highlight childcare precarity as a social determinant of women's health for researchers, clinicians, and decision-makers.
MeSH term(s)	Child ; Humans ; Female ; Child, Preschool ; Child Care ; Maternal Health ; Reproducibility of Results ; Mothers ; Surveys and Questionnaires
Language	English
Publishing date	2023-11-17
Publishing country	United States
Document type	Journal Article
ZDB-ID	1085396-0
ISSN	1878-4321 ; 1049-3867
ISSN (online)	1878-4321
ISSN	1049-3867
DOI	10.1016/j.whi.2023.10.002
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.A 3298: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (2.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: Cost-effectiveness analysis alongside the inter-B-NHL ritux 2010 trial: rituximab in children and adolescents with B cell non-Hodgkin's lymphoma.

Lueza, Béranger / Aupérin, Anne / Rigaud, Charlotte / Gross, Thomas G / Pillon, Marta / Delgado, Rafael F / Uyttebroeck, Anne / Amos Burke, G A / Zsíros, József / Csóka, Monika / Simonin, Mathieu / Patte, Catherine / Minard-Colin, Véronique / Bonastre, Julia

The European journal of health economics : HEPAC : health economics in prevention and care

2023 Volume 25, Issue 2, Page(s) 307–317

Abstract: Objectives: The randomized controlled trial Inter-B-NHL ritux 2010 showed overall survival (OS) benefit and event-free survival (EFS) benefit with the addition of rituximab to standard Lymphomes Malins B (LMB) chemotherapy in children and adolescents ... ...

Abstract	Objectives: The randomized controlled trial Inter-B-NHL ritux 2010 showed overall survival (OS) benefit and event-free survival (EFS) benefit with the addition of rituximab to standard Lymphomes Malins B (LMB) chemotherapy in children and adolescents with high-risk, mature B cell non-Hodgkin's lymphoma. Our aim was to assess the cost-effectiveness of rituximab-chemotherapy versus chemotherapy alone in the French setting. Methods: We used a decision-analytic semi-Markov model with four health states and 1-month cycles. Resource use was prospectively collected in the Inter-B-NHL ritux 2010 trial (NCT01516580). Transition probabilities were assessed from patient-level data from the trial (n = 328). In the base case analysis, direct medical costs from the French National Insurance Scheme and life-years (LYs) were computed in both arms over a 3-year time horizon. Incremental net monetary benefit and cost-effectiveness acceptability curve were computed through a probabilistic sensitivity analysis. Deterministic sensitivity analysis and several sensitivity analyses on key assumptions were also conducted, including one exploratory analysis with quality-adjusted life years as the health outcome. Results: OS and EFS benefits shown in the Inter-B-NHL ritux 2010 trial translated into the model by rituximab-chemotherapy being the most effective and also the least expensive strategy over the chemotherapy strategy. The mean difference in LYs between arms was 0.13 [95% CI 0.02; 0.25], and the mean cost difference € - 3 710 [95% CI € - 17,877; € 10,525] in favor of rituximab-chemotherapy group. For a € 50,000 per LY willingness-to-pay threshold, the probability of the rituximab-chemotherapy strategy being cost-effective was 91.1%. All sensitivity analyses confirmed these findings. Conclusion: Adding rituximab to LMB chemotherapy in children and adolescents with high-risk mature B-cell non-Hodgkin's lymphoma is highly cost-effective in France. Trial registration: ClinicalTrials.gov identifier: NCT01516580.
MeSH term(s)	Child ; Humans ; Adolescent ; Rituximab/therapeutic use ; Cost-Effectiveness Analysis ; Cost-Benefit Analysis ; Progression-Free Survival ; Lymphoma, Non-Hodgkin/drug therapy ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use
Chemical Substances	Rituximab (4F4X42SYQ6)
Language	English
Publishing date	2023-04-14
Publishing country	Germany
Document type	Journal Article
ZDB-ID	2045253-6
ISSN	1618-7601 ; 1618-7598
ISSN (online)	1618-7601
ISSN	1618-7598
DOI	10.1007/s10198-023-01581-y
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.A 5475: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (2.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: Estrogen Receptor Mutations as Novel Targets for Immunotherapy in Metastatic Estrogen Receptor-positive Breast Cancer.

Goldberg, Jonathan / Qiao, Na / Guerriero, Jennifer L / Gross, Brett / Meneksedag, Yagiz / Lu, Yoshimi F / Philips, Anne V / Rahman, Tasnim / Meric-Bernstam, Funda / Roszik, Jason / Chen, Ken / Jeselsohn, Rinath / Tolaney, Sara M / Peoples, George E / Alatrash, Gheath / Mittendorf, Elizabeth A

Cancer research communications

2024 Volume 4, Issue 2, Page(s) 496–504

Abstract: Estrogen receptor-positive (ER+) breast cancer is not considered immunogenic and, to date, has been proven resistant to immunotherapy. Endocrine therapy remains the cornerstone of treatment for ER+ breast cancers. However, constitutively activating ... ...

Abstract	Estrogen receptor-positive (ER+) breast cancer is not considered immunogenic and, to date, has been proven resistant to immunotherapy. Endocrine therapy remains the cornerstone of treatment for ER+ breast cancers. However, constitutively activating mutations in the estrogen receptor alpha (ESR1) gene can emerge during treatment, rendering tumors resistant to endocrine therapy. Although these mutations represent a pathway of resistance, they also represent a potential source of neoepitopes that can be targeted by immunotherapy. In this study, we investigated ESR1 mutations as novel targets for breast cancer immunotherapy. Using machine learning algorithms, we identified ESR1-derived peptides predicted to form stable complexes with HLA-A0201. We then validated the binding affinity and stability of the top predicted peptides through in vitro binding and dissociation assays and showed that these peptides bind HLA-A0201 with high affinity and stability. Using tetramer assays, we confirmed the presence and expansion potential of antigen-specific CTLs from healthy female donors. Finally, using in vitro cytotoxicity assays, we showed the lysis of peptide-pulsed targets and breast cancer cells expressing common ESR1 mutations by expanded antigen-specific CTLs. Ultimately, we identified five peptides derived from the three most common ESR1 mutations (D538G, Y537S, and E380Q) and their associated wild-type peptides, which were the most immunogenic. Overall, these data confirm the immunogenicity of epitopes derived from ESR1 and highlight the potential of these peptides to be targeted by novel immunotherapy strategies. Significance: Estrogen receptor (ESR1) mutations have emerged as a key factor in endocrine therapy resistance. We identified and validated five novel, immunogenic ESR1-derived peptides that could be targeted through vaccine-based immunotherapy.
MeSH term(s)	Female ; Humans ; Breast Neoplasms/genetics ; Receptors, Estrogen/genetics ; Mutation ; Immunotherapy ; Peptides/genetics
Chemical Substances	Receptors, Estrogen ; Peptides
Language	English
Publishing date	2024-02-09
Publishing country	United States
Document type	Journal Article ; Research Support, Non-U.S. Gov't
ISSN	2767-9764
ISSN (online)	2767-9764
DOI	10.1158/2767-9764.CRC-23-0244
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Inter-library loan at ZB MED

Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

Article: The cognitive impact of atrial fibrillation.

Gross, Anne F / Stern, Theodore A

The primary care companion for CNS disorders

2013 Volume 15, Issue 1

Language	English
Publishing date	2013-01-10
Publishing country	United States
Document type	Journal Article
ZDB-ID	2127230-X
ISSN	1478-7954 ; 2155-7772
ISSN (online)	1478-7954
ISSN	2155-7772
DOI	10.4088/PCC.12f01471
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Article ; Online: Intravenous haloperidol: A systematic review of side effects and recommendations for clinical use.

Beach, Scott R / Gross, Anne F / Hartney, Kimberly E / Taylor, John B / Rundell, James R

General hospital psychiatry

2020 Volume 67, Page(s) 42–50

Abstract: Introduction: Though not approved by the United States Food and Drug Administration, intravenous haloperidol (IVH) is widely used off-label to manage agitation and psychosis in patients with delirium in the hospital setting. Over the years, concerns ... ...

Abstract	Introduction: Though not approved by the United States Food and Drug Administration, intravenous haloperidol (IVH) is widely used off-label to manage agitation and psychosis in patients with delirium in the hospital setting. Over the years, concerns have emerged regarding side effects of IVH, particularly its potential to cause QT prolongation, torsades de pointes (TdP), extrapyramidal symptoms and catatonia. Methods: We conducted a systematic review of literature of published literature related to side effects of IVH in PubMed in accordance with PRISMA guidelines. Results: 77 of 196 identified manuscripts met inclusion criteria, including 34 clinical trials and 34 case reports or series. Discussion: Extrapyramidal symptoms, catatonia and neuroleptic malignant syndrome appears to be relatively rare with IVH. In most prospective studies, IVH did not cause greater QT prolongation than placebo, and rates of TdP with IVH appear to be low. There is not clear evidence to suggest that IVH carries greater risk for QT prolongation or TdP than other antipsychotics. Conclusions: Based on the available literature, we provide modified evidence-based monitoring recommendations for clinicians prescribing IVH in hospital settings. Specifically, we recommend electrocardiogram monitoring only when using doses >5 mg of IVH and telemetry only for high-risk patients receiving cumulative doses of at least 100 mg or with accurately corrected QTc >500 ms.
MeSH term(s)	Antipsychotic Agents/adverse effects ; Electrocardiography ; Haloperidol/adverse effects ; Humans ; Long QT Syndrome ; Prospective Studies ; Torsades de Pointes
Chemical Substances	Antipsychotic Agents ; Haloperidol (J6292F8L3D)
Language	English
Publishing date	2020-08-22
Publishing country	United States
Document type	Journal Article ; Review ; Systematic Review
ZDB-ID	392299-6
ISSN	1873-7714 ; 0163-8343
ISSN (online)	1873-7714
ISSN	0163-8343
DOI	10.1016/j.genhosppsych.2020.08.008
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.A 1584: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (1.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: DNA damage signaling in

Hersperger, Fabian / Meyring, Tim / Weber, Pia / Chhatbar, Chintan / Monaco, Gianni / Dionne, Marc S / Paeschke, Katrin / Prinz, Marco / Groß, Olaf / Classen, Anne-Kathrin / Kierdorf, Katrin

eLife

2024 Volume 12

Abstract: Environmental factors, infection, or injury can cause oxidative stress in diverse tissues and loss of tissue homeostasis. Effective stress response cascades, conserved from invertebrates to mammals, ensure reestablishment of homeostasis and tissue repair. ...

Abstract	Environmental factors, infection, or injury can cause oxidative stress in diverse tissues and loss of tissue homeostasis. Effective stress response cascades, conserved from invertebrates to mammals, ensure reestablishment of homeostasis and tissue repair. Hemocytes, the
MeSH term(s)	Animals ; Drosophila ; Oxidative Stress ; Macrophages ; Arthropods ; Cytokines ; DNA Damage ; Mammals
Chemical Substances	Cytokines
Language	English
Publishing date	2024-01-08
Publishing country	England
Document type	Journal Article
ZDB-ID	2687154-3
ISSN	2050-084X ; 2050-084X
ISSN (online)	2050-084X
ISSN	2050-084X
DOI	10.7554/eLife.86700
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Article ; Online: Neuropsychiatric conditions associated with anesthesia exposure.

Gross, Anne F / Stern, Theodore A

Psychosomatics

2014 Volume 55, Issue 1, Page(s) 21–28

Abstract: Background: Although anesthetics have been used for more than a century, their mechanisms of action remain poorly understood. Given that a number of intraoperative and postoperative neuropsychiatric syndromes have been linked to the use of anesthetics, ... ...

Abstract	Background: Although anesthetics have been used for more than a century, their mechanisms of action remain poorly understood. Given that a number of intraoperative and postoperative neuropsychiatric syndromes have been linked to the use of anesthetics, practitioners should familiarize themselves with these conditions. Methods: Basic concepts about anesthesia are reviewed and neuropsychiatric syndromes associated with anesthesia exposure described. Conclusions: Emergence delirium, postoperative delirium, postoperative cognitive dysfunction, and intraoperative awareness can develop in association with use of inhalation anesthetics and intravenously administered anesthetics.
MeSH term(s)	Anesthesia, General/adverse effects ; Anesthesia, General/psychology ; Cognition Disorders/psychology ; Delirium/psychology ; Humans ; Intraoperative Awareness/psychology ; Postoperative Complications/psychology ; Stress Disorders, Post-Traumatic/psychology
Language	English
Publishing date	2014-01
Publishing country	England
Document type	Journal Article ; Review
ZDB-ID	209487-3
ISSN	1545-7206 ; 0033-3182
ISSN (online)	1545-7206
ISSN	0033-3182
DOI	10.1016/j.psym.2013.06.020
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.A 440: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (1.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: Weighing risks and benefits of prescribing antidepressants during pregnancy.

Silverman, Benjamin C / Gross, Anne F

The virtual mentor : VM

2013 Volume 15, Issue 9, Page(s) 746–752

MeSH term(s)	Antidepressive Agents/adverse effects ; Antidepressive Agents/therapeutic use ; Decision Making ; Depression/complications ; Depression/drug therapy ; Depressive Disorder/complications ; Depressive Disorder/drug therapy ; Ethics, Medical ; Female ; Humans ; Personal Autonomy ; Pregnancy ; Pregnancy Complications/drug therapy ; Prescriptions ; Risk Assessment
Chemical Substances	Antidepressive Agents
Language	English
Publishing date	2013-09
Publishing country	United States
Document type	Journal Article
ISSN	1937-7010
ISSN (online)	1937-7010
DOI	10.1001/virtualmentor.2013.15.9.ecas1-1309
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Inter-library loan at ZB MED

Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

Article: Early detection of malignant and pre-malignant peripheral nerve tumors using cell-free DNA fragmentomics.

Taylor Sundby, R / Szymanski, Jeffrey J / Pan, Alexander / Jones, Paul A / Mahmood, Sana Z / Reid, Olivia H / Srihari, Divya / Armstrong, Amy E / Chamberlain, Stacey / Burgic, Sanita / Weekley, Kara / Murray, Béga / Patel, Sneh / Qaium, Faridi / Lucas, Andrea N / Fagan, Margaret / Dufek, Anne / Meyer, Christian F / Collins, Natalie B /

Pratilas, Christine A / Dombi, Eva / Gross, Andrea M / Kim, AeRang / Chrisinger, John S A / Dehner, Carina A / Widemann, Brigitte C / Hirbe, Angela C / Chaudhuri, Aadel A / Shern, Jack F

medRxiv : the preprint server for health sciences

2024

Abstract: Early detection of neurofibromatosis type 1 (NF1) associated peripheral nerve sheath tumors (PNST) informs clinical decision-making, potentially averting deadly outcomes. Here, we describe a cell-free DNA (cfDNA) fragmentomic approach which distinguishes ...

Abstract	Early detection of neurofibromatosis type 1 (NF1) associated peripheral nerve sheath tumors (PNST) informs clinical decision-making, potentially averting deadly outcomes. Here, we describe a cell-free DNA (cfDNA) fragmentomic approach which distinguishes non-malignant, pre-malignant and malignant forms of NF1 PNST. Using plasma samples from a novel cohort of 101 NF1 patients and 21 healthy controls, we validated that our previous cfDNA copy number alteration (CNA)-based approach identifies malignant peripheral nerve sheath tumor (MPNST) but cannot distinguish among benign and premalignant states. We therefore investigated the ability of fragment-based cfDNA features to differentiate NF1-associated tumors including binned genome-wide fragment length ratios, end motif analysis, and non-negative matrix factorization deconvolution of fragment lengths. Fragmentomic methods were able to differentiate pre-malignant states including atypical neurofibromas (AN). Fragmentomics also adjudicated AN cases suspicious for MPNST, correctly diagnosing samples noninvasively, which could have informed clinical management. Overall, this study pioneers the early detection of malignant and premalignant peripheral nerve sheath tumors in NF1 patients using plasma cfDNA fragmentomics. In addition to screening applications, this novel approach distinguishes atypical neurofibromas from benign plexiform neurofibromas and malignant peripheral nerve sheath tumors, enabling more precise clinical diagnosis and management.
Language	English
Publishing date	2024-03-11
Publishing country	United States
Document type	Preprint
DOI	10.1101/2024.01.18.24301053
Database	MEDical Literature Analysis and Retrieval System OnLINE

Inter-library loan at ZB MED

Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

Details ▾

Article ; Online: Crizotinib in Combination With Chemotherapy for Pediatric Patients With ALK+ Anaplastic Large-Cell Lymphoma: The Results of Children's Oncology Group Trial ANHL12P1.

Lowe, Eric J / Reilly, Anne F / Lim, Megan S / Gross, Thomas G / Saguilig, Lauren / Barkauskas, Donald A / Wu, Rui / Alexander, Sarah / Bollard, Catherine M

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

2022 Volume 41, Issue 11, Page(s) 2043–2053

Abstract: Purpose: Arm crizotinib (CZ) of the Children's Oncology Group trial ANHL12P1 (ClinicalTrials.gov identifier: NCT01979536) examined the efficacy and toxicity of adding CZ to standard chemotherapy for children with newly diagnosed, nonlocalized ALK+ CD30+ ...

Abstract	Purpose: Arm crizotinib (CZ) of the Children's Oncology Group trial ANHL12P1 (ClinicalTrials.gov identifier: NCT01979536) examined the efficacy and toxicity of adding CZ to standard chemotherapy for children with newly diagnosed, nonlocalized ALK+ CD30+ anaplastic large-cell lymphoma (ALCL). Patients and methods: Between 2013 and 2019, 66 enrolled children received CZ with chemotherapy. Patients received a 5-day prophase followed by six chemotherapy cycles at 21-day intervals with CZ administered twice daily during each 21-day cycle. The study was temporarily closed for two periods (total 12 months) to evaluate toxicity, during which CZ was discontinued. Measurements of Results: The 2-year event-free survival (EFS) is 76.8% (95% CI, 68.5 to 88.1) and the 2-year overall survival is 95.2% (95% CI, 85.7 to 98.4). Fifteen patients relapsed and one patient died; median time to relapse was 7.4 months from diagnosis, with relapses occurring after chemotherapy was complete. The 66 patients completed 384 cycles of chemotherapy. Thirteen of the 66 patients experienced a grade 2+ thromboembolic adverse event (19.7%; 95% CI, 11.1 to 31.3). In the 25 patients who received mandated prophylactic anticoagulation, there were two thromboembolic events (8.0%; 95% CI, 0.01 to 26). Patients with negative MDD had a superior outcome, with an EFS of 85.6% (95% CI, 68.6 to 93.8); positive MDD was associated with a lower EFS of 58.1% (95% CI, 33.4 to 76.4). Conclusion: Arm CZ of ANHL12P1 demonstrated that the addition of CZ to standard treatment prevented relapses during therapy for children with ALCL, MDD predicted EFS, and the addition of CZ resulted in unexpected thromboembolic events. Overall survival and EFS rates are consistent with the highest reported outcomes for children with ALCL.
MeSH term(s)	Humans ; Child ; Crizotinib/therapeutic use ; Lymphoma, Large-Cell, Anaplastic/diagnosis ; Receptor Protein-Tyrosine Kinases/therapeutic use ; Neoplasm Recurrence, Local/drug therapy ; Anaplastic Lymphoma Kinase
Chemical Substances	Crizotinib (53AH36668S) ; Receptor Protein-Tyrosine Kinases (EC 2.7.10.1) ; Anaplastic Lymphoma Kinase (EC 2.7.10.1)
Language	English
Publishing date	2022-12-19
Publishing country	United States
Document type	Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
ZDB-ID	604914-x
ISSN	1527-7755 ; 0732-183X
ISSN (online)	1527-7755
ISSN	0732-183X
DOI	10.1200/JCO.22.00272
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.A 1847: Show issues			Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (1.OG) ab Jg. 2022: Lesesaal (EG)
Zs.MO 650: Show issues

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

To top

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

Order via subito

Inter-library loan at ZB MED

More links

Kategorien

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

Order via subito

Inter-library loan at ZB MED

More links

Kategorien

Inter-library loan at ZB MED

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito